UBS Group »

Athira Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6k 932 2.74
2023-12-31 $2.3k 932 2.43
2023-09-30 $201k 100k 2.02
2023-06-30 $83k 28k 2.95
2023-03-31 $59k 24k 2.50
2022-12-31 $326k 103k 3.17
2022-09-30 $193k 65k 2.96
2022-06-30 $173k 57k 3.04
2022-03-31 $760k 56k 13.50
2021-12-31 $172k 13k 13.04
2021-09-30 $644k 69k 9.37
2021-06-30 $13k 1.3k 10.32
2021-03-31 $13k 700 18.57
2020-12-31 $5.6M 164k 34.25
2020-09-30 $461k 25k 18.46